On November 8, 2020, a signing ceremony of cooperation between NeuHelium and MSD was held at China International Import Expo. The two parties will join hands to promote the application of brain-inspired intelligence technology into the pharmaceutical industry.

NeuHelium and MSD sign a cooperation memorandum

As an important branch to make potential breakthrough in the leapfrog development of artificial intelligence, brain-inspired intelligence has become the forefront of global technological and industrial innovation. NeuHelium, as a neuromorphic computing and brain-inspired R&D innovation hub, is committed to creating a cooperation network of brain-inspired intelligence, neuromorphic chips, and AI applications and to promoting the building of a brain-inspired intelligence ecosystem. With the strategic cooperation with MSD, NeuHelium aims to apply the latest artificial intelligence technology driven by brain-inspired intelligence into the pharmaceutical industry, and to offer innovative solutions to promote digital transformation for MSD.

"Joining hands with MSD, a strong partner with leading innovative health solutions, we aim to work together to promote the technology upgrading of the overall pharmaceutical industry by combining MSD’s industrial knowhow with NeuHelium’s research in the fields of brain-inspired computing, data science, deep learning, and knowledge graphs," said CEO of NeuHelium. "I believe this cooperation could contribute to the development of the artificial intelligence industry and provide customers with better services," he added.